|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 11400 TOMAHAWK CREEK PARKWAY |
Address2 |
|
City | LEAWOOD |
State | KS |
Zip Code | 66211-2672 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1342-12
|
||||||||
|
6. House ID# 321800000
|
TYPE OF REPORT | 8. Year | 2016 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Lisa R. Westergaard |
Date | 8/11/2016 12:30:21 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
S. 2956 - FDA authority to regulate tobacco products: Public Health - FDA regulation of tobacco including cigars & e-cigs.
S. 3040 - FY 2017 appropriation for AHRQ: Restore AHRQ funding.
S. 3040 - FY2017 budget request for HRSA Title VII 747: Increase Title VII Primary Care Training & Enhancement funding.
S. 3040 - FY 2017 appropriations for HRSA National Health Services Corp: Provide appropriated funds to support medical student debt relief and increased access.
HR 2577, HR 5243 HR 4973 - Funding for Zika emergency response: Public Health.
HR 4223 - Protecting Our Students by Terminating Graduate Rates that Add to Debt Act: Support legislation that restores graduate and professional students to the Federal Direct Subsidized Loan program.
No Bill No. - Advisory Committee on Training in Primary Care Medicine & Dentistry: Increase support for Title VII.
No Bill No. - Appropriations for FY 2017: Retain funding for HRSA's Title VII Health Professions Grants and for AHRQ.
No Bill No - Zika Budget Meeting: Organized to urge policymakers to fund Zika monies and to support public health infectious disease control.
No Bill No - Mental Health Reform: Educate policy makers about primary care integration, insurance reforms, and workforce policies.
No Bill No - Teaching Health Center Reauthorization: The meetings were organized to seek support for THC permanancy.
No Bill No - FY 2016 appropriations AHRQ, HRSA Title VII, NHSC: AAFP Federal spending priorities to support workforce, research.
No Bill No.- Gun Violence/Appropriations: Encouraging Gun Violence Prevention Research; CDC Gun Violence Research.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
|
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
S. 3040 - FY2017 budget request for HRSA Title VII 747: Increase Title VII Primary Care Training & Enhancement funding.
S. 3040 - FY 2017 appropriations for HRSA National Health Services Corp: Provide appropriated funds to support medical student debt relief and increased access.
HR 4223 - Protecting our Students by Terminating Graduate Rates that Add to Debt Act: medical student debt relief POST GRAD Act.
No Bill No.-Graduate Medical Education: Advocate for introduction of a bill to fix problem caused by "rotators" who establish low caps and PRAs.
No Bill No.-Graduate Medical Education: Advocate for solution to VACAA Expansion slots - how to fill them with more family medicine residents.
No Bill No. - Graduate Medical Education: Advocate for the introduction of a bill to help resolve problems specific to the rural GME.
No Bill No. - Teaching Health Center Graduate Medical Education permanence: Maintain the sustainability of the THCGME program.
No Bill No. - 2016 Family Medicine Congressional Conference: MACRA curb RX abuse, THCGME, workforce and research.
No Bill No. - National Advisory Council on the National Health Service Corps: NHSC-scholarships, student debt repayment, access .
No Bill No. - Advisory Committee on Training in Primary Care Medicine and Dentistry: Increase support for Title VII.
No Bill No. - Nomination to HRSA NACNHSC - naming a family physician to the NACNHSC.
No Bill No. - Nomination to HRSA ACTPCMD - naming a family physicians and/or teacher of family medicine.
No Bill No.- FY2017 appropriations: Retain funding for HRSA's Title VII Health Professions Grants and for AHRQ.
No Bill No. - Prescription Drug Abuse: Invest in prescription drug monitoring programs and physician education.
No Bill No - Mental Health Reform: Educate policy makers about primary care integration, insurance reforms, and workforce policies.
No Bill No - Teaching Health Center Reauthorization: The meetings were organized to seek support for THC permanancy.
No Bill No. - FY 2016 appropriations AHRQ, HRSA Title VII, NHSC: AAFP Federal spending priorities to support workforce, research.
No Bill No. - Graduate Medical Education - Explain and advocate for AAFP's policy proposals on GME.
No Bill No. - Congressional Primary Care Caucus - Urge members to join the Caucus and support Primary Care to achieve the triple aim in health care.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Andrew |
Adair |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Sonya |
Clay |
|
|
|
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S. 285 Promise for Antibiotics and Therapeutics for Health Act: Support streamlining FDA's approval process for treatments of antibiotic resistant bacteria.
S 524 HR 953 HR 1725 HR 4981 HR 4599 HR 3680 HR 4586 HR 4969 HR 4641 HR 5046 - Comprehensive Addiction & Recovery Act: Support state prescription drug monitoring, treatment, naloxone, take-backs, partial fil & evidence based prescribing & treatment.
S. 2742 Promoting Bomedical Research and Public Health for Patients Act: Improve how CDC engages vaccine manufacturers.
S. 2822/HR 5001 Flexibility in Electronic Health Record Reporting Act: Shorten EHR reporting period in Meaningful Use to 90 days.
S. 2956 - FDA authority to regulate tobacco products: Protect FDA authority over tobacco products including cigars and e-cigs.
S. 3040 - FY2017 appropriations for AHRQ, Restore AHRQ appropriation.
S. 3040 - FY 2017 appropriations for HRSA National Health Services Corp: Provide appropriated funds to support medical student debt relief and increased access.
HR 2577, HR 5243 HR 4973 - Public Health/Emergency Funding: Funding for Zika emergency response: Public Health.
HR 4223 - Protecting Our Students by Terminating Graduate Rates that Add to Debt Act: Support legislation that restores graduate and professional students to the Federal Direct Subsidized Loan program.
HR 4771 - Medical Liability Reform: Support Help Efficient, Accessible, Low Cost, Timely Health Care "HEALTH" Act: Medical Liability Reform - the HEALTH Act.
No Bill No - Teaching Health Center Reauthorization: The meetings were organized to seek support for THC permanancy.
No Bill No. - FY 2016 appropriations AHRQ, HRSA Title VII, NHSC: AAFP Federal spending priorities to support workforce, research.
No Bill No. - Graduate Medical Education - Explain and advocate for AAFP's policy proposals on GME.
No Bill No. - Congressional Primary Care Caucus - Urge members to join the Caucus and support Primary Care to achieve the triple aim in health care.
No Bill No. - Gun Violence/Appropriations: CDC Gun Violence research.
No Bill No.- Health IT: Advocate for Introduction of a Bill to reduce Meaningful Use Reporting Period for 2016 to 90 days.
No Bill No.-Graduate Medical Education: Pursue advancement of a bill to fix problem caused by "rotators" who establish low caps and PRAs.
No Bill No. - Physician Payment Reform: Work with House Committee on Energy and Commerce on oversight of MACRA implementation, including hearing preparation.
No Bill No. - Physician Payment Reform: Provide TA to House office on bill relating to payment and delivery reform around end-of-life care.
No Bill No.-Graduate Medical Education: Advocate for solution to VACAA Expansion slots - how to fill them with more family medicine residents.
No Bill No. - Graduate Medical Education: Advocate for the introduction of a bill to help resolve problems specific to the rural GME.
No Bill No. - Physician Payment Reform: Advocate for advancement of policies that would promote direct primary care (DPC)
No Bill No. - Physician Payment Reform: Advise W&M COmmittee on AAFP's position on the CMS Part B Drug Demonstration.
No Bill No. - Physician Payment Reform: Help AAFP team with drafting comments to MIPS/APMs proposed rulemaking.
No Bill No. - Teaching Health Center Graduate Medical Education permanence: Maintain the sustainability of the THCGME program.
No Bill No. - HHS External Opioid Working Group: Meeting AAFP commitment to curb prescription opioid abuse.
No Bill No. - Encourage House members to join Primary Care Caucus: Increase membership of the Primary Care Caucus.
No Bill No. - 2016 Family Medicine Congressional Conference: MACRA curb RX abuse, THCGME, workforce and research.
No Bill No. - Primary Care Forum: Robert Graham Center Research.
No Bill No. - Friends of AHRQ - Primary Care Research & Support for PC transformation.
No Bill No. - National Advisory Council on the National Health Service Corps: NHSC-scholarships, student debt repayment, access .
No Bill No. - Advisory Committee on Training in Primary Care Medicine and Dentistry: Increase support for Title VII.
No Bill No. - Nomination to HRSA NACNHSC - naming a family physician to the NACNHSC.
No Bill No. - Nomination to HRSA ACTPCMD - naming a family physicians and/or teacher of family medicine.
No Bill No. - Health IT/90 Day bill: Meeting to urge policy makers to support Meaningful Use flexibility legislation.
No Bill No. - Zika Budget Meeting: Meeting to urge policy makers to fund Zika monies and to support public health infectious disease control.
No Bill No.- FY2017 appropriations: Retain funding for HRSA's Title VII Health Professions Grants and for AHRQ.
No Bill No.- Ban on public finding for research into gun violence: End restrictions on research into gun violence.
No Bill No. - FDA final rule on coverage of tobacco regulatory authority: Recommend that OMB release FDA final "deeming" rule on tobacco control authority.
No Bill No. - Medicare Access and CHIP Reauthorization Act (MACRA): Testified that CMS needs to support primary care in upcoming proposed rule on MACRA.
No Bill No. - Prescription Drug Abuse: Invest in prescription drug monitoring programs and physician education.
No Bill No. - FDA regulatory authority over tobacco products: Eliminate House Agriculture appropriations bill's exemption of cigars from FDA regulation and the softening of pre-market review requirements of e-cigarettes.
No Bill No. - Implementation of MACRA by CMS: Make sure primary care physicians have a clear path to Alternative Payment Models.
No Bill No. - Mental Health reforms: Coverage of mental health services by family physicians.
No Bill No. - Medicare Part B Drug Demonstration Program: Support value-based purchasing of Medicare Part Drugs.
No Bill No. - Interoperability of Information Systems: Measure key compoents of HIT interoperability.
No Bill No.- Rural Training Tracks: Production of primary care physicians is needed to meet needs of rural America.
No Bill No. - MACRA proposed rule: Preserve the role of primary care in the physician payment system.
No Bill No. - Confidentiality of Substance Use Disorder Patient Records: Patient privacy, EHRs.
No Bill No. - Hep C virus administration by PCPs: Ability of PCPs to admin hep c treatment.
No Bill No. - PCP recommendations for MACRA: PCP recs for the MACRA proposed rule.
PCP prescribing diabetic testing supplies: Admin hassles with prescribing for diabetic patients.
No Bill No. - Nomination for Health Promotion: Nominating FPs to an HHS committee.
No Bill No. - FDA Regulation over nicotine delivery devices: Urging the Administration to finalize the FDA deeming regulations over tobacco.
No Bill No. - How MACRA should be implemented: Sign on letter to CMS on MACRA implementation.
No Bill No. - Urging the APOE to cover MA: Urging CMS's outreach office to educate on Medicare Advantage plans.
No Bill No. - Contraceptives for men and women: Urging CMS to cover contraceptives for all.
No Bill No. - CMS on the PCMH: How CMS and MACRA should consider the PCMH.
No Bill No. - MY and interoperability issues and MACRA: Further meaningful use concerns.
No Bill No. - Nominating FPs to a primary workgroup: Putting FPs on a primary care committee.
No Bill No. - VA on prescription drug monitoring programs: That VA should follow state based PDMPs.
No Bill No. - Medicare Part B Drug proposed rule: Concerns with rising Part B and D costs.
No Bill No. - USPSTF nominations: Getting FPs on the USPSTF.
No Bill No. - RFI on interoperability and MACRA: Further EHR suggestions.
No Bill No. - GME provisions withing IPPS regulation: Need more GME slots for rural PCPs.
No Bill No. - comments on antibiotic resistant bacteria: How to combat antibiotic resistant bacteria.
No Bill No. - Comments on the MACRA proposed rule: 107 page comment letter on the MACRA proposed rule.
No Bill No. - Health Insurance Marketplace issues and Provider Involvement with Patient Enrollment: Network adequacy, Patient Enrollment in Marketplaces.
No Bill No. - Childrens Health Insurance: CHIP Medicaid.
No Bill No. - VA Nursing Handbook: Scope of Practice.
No Bill No. - Medicaid: Medicaid alternative Proposals.
No Bill No. - MACRA: Meetings to discuss current efforts to prepare for the MACRA law.
No Bill No. - Adult Vaccine Meeting - Meetings to discuss current efforts to increase adult vaccine access through Medicare access and interoperability.
No Bill No. - Mental Health Reform: Engagement to educate policy makers about primary care integration, insurance reforms and workforce policies.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), White House Office, Health & Human Services - Dept of (HHS), Agency for Healthcare Research & Quality (AHRQ), Health Resources & Services Administration (HRSA), Veterans Affairs - Dept of (VA), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Andrew |
Adair |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Robert |
Bennett |
|
|
|
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
|
Shannon |
Morey |
|
|
|
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
S. 2822/HR 5001 Flexibility in Electronic Health Record Reporting Act: Shorten EHR reporting period in Meaningful Use to 90 days.
No Bill No. - Teaching Health Center Graduate Medical Education permanence: Maintain the sustainability of the THCGME program.
No Bill No. - Graduate Medical Education - Explain and advocate for AAFP's policy proposals on GME.
No Bill No. - Congressional Primary Care Caucus - Urge members to join the Caucus and support Primary Care to achieve the triple aim in health care.
No Bill No.- Health IT: Advocate for Introduction of a Bill to reduce Meaningful Use Reporting Period for 2016 to 90 days.
No Bill No.-Graduate Medical Education: Advocate for introduction of a bill to fix problem caused by "rotators" who establish low caps and PRAs.
No Bill No. - Physician Payment Reform: Work with House Committee on Energy and Commerce on oversight of MACRA, including hearing preparation.
No Bill No. - Physician Payment Reform: Provide TA to House office on bill relating to payment and delivery reform around end-of-life care.
No Bill No. - Physician Payment Reform: Advocate for advancement of policies that would promote direct primary care (DPC)
No Bill No. - Physician Payment Reform: Advise W&M COmmittee on AAFP's position on the CMS Part B Drug Demonstration.
No Bill No. - Physician Payment Reform: Help AAFP team with drafting comments to MIPS/APMs proposed rulemaking.
No Bill No. - Teaching Health Center Graduate Medical Education permanence: Maintain the sustainability of the THCGME program.
No Bill No. - HHS External Opioid Working Group: Meeting AAFP commitment to curb prescription opioid abuse.
No Bill No. - Encourage House members to join Primary Care Caucus: Increase membership of the Primary Care Caucus.
No Bill No. - 2016 Family Medicine Congressional Conference: MACRA curb RX abuse, THCGME, workforce and research.
No Bill No. - Medicare Access and CHIP Reauthorization Act (MACRA): Testified that CMS needs to support Primary Care in upcoming proposed rule on MACRA.
No Bill No. - Implementation of MACRA by CMS: Make sure primary care physicians have a clear path to Alternative Payment Models.
No Bill No. - Mental Health reforms: Coverage of mental health services by family physicians.
No Bill No. - Medicare Part B Drug Demonstration Program: Support value-based purchasing of Medicare Part Drugs.
No Bill No.- Rural Training Tracks: Production of primary care physicians is needed to meet needs of rural America.
No Bill No. - MACRA proposed rule: Preserve the role of primary care in the physician payment system.
No Bill No. - Confidentiality of Substance Use Disorder Patient Records: Patient privacy, EHRs.
No Bill No. - Hep C virus administration by PCPs: Ability of PCPs to admin hep c treatment.
No Bill No. - How MACRA should be implemented: Sign on letter to CMS on MACRA Implementation.
No Bill No. - CMS on the PCMH: How CMS and MACRA should consider the PCMH.
No Bill No. - MY and interoperability issues and MACRA: Further meaningful use concerns.
No Bill No. - Nominating FPs to a primary workgroup: Putting FPs on a primary care committee.
No Bill No. - VA on prescription drug monitoring programs: That VA should follow state based PDMPs.
No Bill No. - Comments on the MACRA proposed rule: 107 page comment letter on the MACRA proposed rule.
No Bill No. - Health IT/90 Day bill: Meeting to urge policy makers to support Meaningful Use flexibility legislation.
No Bill No. - Zika Budget Meeting: Meeting to urge policy makers to fund Zika monies and to support public health infectious disease control.
No Bill No. - MACRA: Meetings to discuss current efforts to prepare for the MACRA law.
No Bill No. - Adult Vaccine Meeting - Meetings to discuss current efforts to increase adult vaccine access through Medicare access and interoperability.
No Bill No. - Mental Health Reform: Engagement to educate policy makers about primary care integration, insurance reforms and workforce policies.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), White House Office, Health & Human Services - Dept of (HHS), Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Andrew |
Adair |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Robert |
Bennett |
|
|
|
Kevin |
Burke |
|
Deputy Assistant at HHS |
|
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
S. 2956 - FDA authority to regulate tobacco products: Public Health - FDA regulation of tobacco including cigars & e-cigs; Eliminate House Agriculture appropriations bill's exemption of cigars from FDA regulation and the softening of pre-market review requirements of e-cigarettes.
No Bill No. - FDA final rule on coverage of tobacco regulatory authority: Recommend that OMB release FDA final "deeming" rule on tobacco control authority.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
|
Teresa |
Baker |
|
House Legislative Asst, Analyst and Director |
|
Mark |
Cribben |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FIR
16. Specific lobbying issues
No Bill No. - Ban on public funding for research into gun violence: End restriction on research into gun violence.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ALC
16. Specific lobbying issues
s. 524 - Comprehensive Addiction and Recovery Act: Support state prescription drug monitoring, treatment, naloxone, take-backs, partial fill & evidence based prescribing treatment.
No Bill No - HHS External Opioid Working Group: AAFP commitment to curb prescription opioid abuse.
No Bill No - 2016 Family Medicine Congressional Conference: MACR, curb RX abuse, THCGME, workforce and research.
No Bill No. - Champions of Change for Advancing Prevention, Treatment and Recovery: Curb RX abuse, increase treatment.
No Bill No. - Prescription Drug Abuse: Invest in prescription drug monitoring programs and physician education.
17. House(s) of Congress and Federal agencies Check if None
Health & Human Services - Dept of (HHS), White House Office, U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa |
Baker |
|
House Legislative Assistant, Analyst & Director |
|
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
HR 4771 Medical Liability Reform: Support Help Efficient, Accessible, Low-cost, Timely Healthcare "HEALTH" Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa |
Baker |
|
House Legislative Assistant, Analyst and Director |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
No Bill No.- Gun Violence/Appropriations: CDC Gun Violence Research.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
S. 285 Promise for Antibiotics and Therapeutics for Health Act: Support streamlining FDA's approval process for treatments of antibiotic resistant bacteria.
S. 2742 Promoting Bomedical Research and Public Health for Patients Act: Improve how CDC engages vaccine manufacturers.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |